相关实验视频
Updated: Jun 30, 2025

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.7K
设计,合成,抗瘤活动评估和模拟一些2-阿米诺皮拉衍生物的分子动力学
Hangrui Cui1, Ruifeng Zhang1, Xin Xiong1
1Institute of Advanced Pharmaceutical Technology, Department of Pharmacy, College of Medicine, Wuhan University of Science and Technology, Wuhan, 430081, China.
Current computer-aided drug design
|March 14, 2024
概括
研究人员合成了新型的2-aminopyrazine衍生物,确定了化合物3e作为一种强大的抗瘤剂. 这种化合物有效地抑制了癌细胞的生长,并诱导了亡,因此需要进一步研究药物开发.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 计算化学的计算化学
背景情况:
- 癌症仍然是一个重大的全球健康挑战,需要开发新的治疗药物.
- 2-阿米诺皮拉基架已被证明是抗瘤化合物的基础,特别是那些针对SHP2.的药物.
- 识别新的强效抑制剂对于推进癌症治疗策略至关重要.
研究的目的:
- 合成和评估其抗瘤潜力的新型2-aminopyrazine衍生物.
- 为了确定具有针对癌症细胞系的增强抑制活性的特定化合物.
- 阐明最强效化合物的作用机制,包括SHP2抑制.
主要方法:
- 合成12种新型的2 - 氨皮拉衍生物.
- 使用光谱技术进行结构确认.
- 使用MTT试验对MDA-MB-231和H1975癌细胞系的抗瘤活性进行体外评估.
- 通过流动细胞计量进行亡诱导分析.
- 计算研究包括分子对接和分子动力学模拟.
主要成果:
- 化合物3e对H1975和MDA-MB-231细胞表现出显著的强有力的抗瘤活性,IC50值分别为11.84±0.83μM和5.66±2.39μM.
- 化合物3e的活性超过了已知的SHP2抑制剂GS493.
- 流细胞计证实,化合物3e在H1975细胞中诱导了亡.
- 计算分析表明,SHP2被化合物3e选择性抑制.
结论:
- 一种新的2-aminopyrazine衍生物,化合物3e,已成功合成,并表现出强大的抗瘤活性.
- 化合物3e有效抑制H1975和MDA-MB-231癌细胞的增殖,并诱导细胞亡.
- 这些发现支持进一步调查化合物3e作为抗瘤药物开发的潜在候选者,可能通过SHP2抑制.
相关概念视频
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Preparation of 1° Amines: Azide Synthesis
3.9K
Direct alkylation of ammonia produces polyalkylated amines, along with a quaternary ammonium salt. To exclusively prepare primary amines, the azide synthesis method can be used.
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
3.9K
Basicity of Heterocyclic Aromatic Amines
6.0K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.0K
Physical Properties of Amines
3.1K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.1K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.0K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K

